Melanoma side population cell (Melanoma SP cell)

Melanoma side population (SP) cells are a specialized sub-fraction of melanoma cells identified by their unique ability to efflux Hoechst 33342 dye through ATP-binding cassette (ABC) transporters, such as ABCG2, ABCB1, and ABCB5. This population is widely regarded as being enriched for cancer stem cell (CSC) or melanoma-initiating cell (MIC) properties, including high tumorigenicity, the capacity for self-renewal, and a primitive molecular phenotype. These cells play a critical role in clinical drug resistance and disease progression because their active efflux mechanisms allow them to survive conventional chemotherapy and certain targeted therapies, eventually leading to tumor relapse and metastasis. While the side population is a cellular phenotype rather than a single molecular entity, specific proteins that define this population, such as ABCB5, have emerged as potential therapeutic targets for monoclonal antibodies. Targeted strategies against this population aim to sensitize melanoma to treatment by inhibiting transporter-mediated efflux or directly eliminating the stem-like cells responsible for tumor maintenance.

Other names

Melanoma side populationMelanoma SPMelanoma stem-like cellMelanoma-initiating cell (MIC)Malignant-melanoma-initiating cell (MMIC)Hoechst-low melanoma cell

Active efflux of xenobiotics and chemotherapeutic agents via ATP-binding cassette (ABC) transporters, specifically ABCG2, ABCB1, and ABCB5, to maintain low intracellular drug concentrations.